Muhammad Osman1, Karen du Preez2, James A Seddon2,3, Mareli M Claassens2,4, Rory Dunbar2, Sicelo S Dlamini5, Alex Welte6, Pren Naidoo2, Anneke C Hesseling2. 1. Desmond Tutu Tuberculosis Centre, Departments of Paediatrics and Child Health and mosman@sun.ac.za. 2. Desmond Tutu Tuberculosis Centre, Departments of Paediatrics and Child Health and. 3. Department of Infectious Diseases, Imperial College London, London, United Kingdom. 4. Department of Biochemistry and Microbiology, School of Medicine, University of Namibia, Windhoek, Namibia; and. 5. Research Information Monitoring, Evaluation, and Surveillance, National Tuberculosis Control and Management Cluster, National Department of Health, Pretoria, South Africa. 6. Science and Innovation, Natrional Research Foundation, South African Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
Abstract
BACKGROUND: In South Africa, tuberculosis (TB) is a leading cause of death among those <20 years of age. We describe changes in TB mortality among children and adolescents in South Africa over a 13-year period, identify risk factors for mortality, and estimate excess TB-related mortality. METHODS: Retrospective analysis of all patients <20 years of age routinely recorded in the national electronic drug-susceptible TB treatment register (2004-2016). We developed a multivariable Cox regression model for predictors of mortality and used estimates of mortality among the general population to calculate standardized mortality ratios (SMRs). RESULTS: Between 2004 and 2016, 729 463 children and adolescents were recorded on TB treatment; 84.0% had treatment outcomes and 2.5% (18 539) died during TB treatment. The case fatality ratio decreased from 3.3% in 2007 to 1.9% in 2016. In the multivariable Cox regression model, ages 0 to 4, 10 to 14, and 15 to 19 years (compared with ages 5 to 9 years) were associated with increased risk of mortality, as was HIV infection, previous TB treatment, and extrapulmonary involvement. The SMR of 15 to 19-year-old female patients was more than double that of male patients the same age (55.3 vs 26.2). Among 10 to 14-year-olds and those who were HIV-positive, SMRs increased over time. CONCLUSIONS: Mortality in South African children and adolescents treated for TB is declining but remains considerable, with 2% dying during 2016. Adolescents (10 to 19 years) and those people living with HIV have the highest risk of mortality and the greatest SMRs. Interventions to reduce mortality during TB treatment, specifically targeting those at highest risk, are urgently needed.
BACKGROUND: In South Africa, tuberculosis (TB) is a leading cause of death among those <20 years of age. We describe changes in TB mortality among children and adolescents in South Africa over a 13-year period, identify risk factors for mortality, and estimate excess TB-related mortality. METHODS: Retrospective analysis of all patients <20 years of age routinely recorded in the national electronic drug-susceptible TB treatment register (2004-2016). We developed a multivariable Cox regression model for predictors of mortality and used estimates of mortality among the general population to calculate standardized mortality ratios (SMRs). RESULTS: Between 2004 and 2016, 729 463 children and adolescents were recorded on TB treatment; 84.0% had treatment outcomes and 2.5% (18 539) died during TB treatment. The case fatality ratio decreased from 3.3% in 2007 to 1.9% in 2016. In the multivariable Cox regression model, ages 0 to 4, 10 to 14, and 15 to 19 years (compared with ages 5 to 9 years) were associated with increased risk of mortality, as was HIV infection, previous TB treatment, and extrapulmonary involvement. The SMR of 15 to 19-year-old female patients was more than double that of male patients the same age (55.3 vs 26.2). Among 10 to 14-year-olds and those who were HIV-positive, SMRs increased over time. CONCLUSIONS: Mortality in South African children and adolescents treated for TB is declining but remains considerable, with 2% dying during 2016. Adolescents (10 to 19 years) and those people living with HIV have the highest risk of mortality and the greatest SMRs. Interventions to reduce mortality during TB treatment, specifically targeting those at highest risk, are urgently needed.
Authors: Peter C Drobac; Sonya S Shin; Pedro Huamani; Sidney Atwood; Jennifer Furin; Molly F Franke; Charmaine Lastimoso; Hernan del Castillo Journal: Pediatrics Date: 2012-07-23 Impact factor: 7.124
Authors: Y D Mukadi; S Z Wiktor; I M Coulibaly; D Coulibaly; A Mbengue; A M Folquet; A Ackah; M Sassan-Morokro; D Bonnard; C Maurice; C Nolan; J K Kreiss; A E Greenberg Journal: AIDS Date: 1997-07-15 Impact factor: 4.177
Authors: Eric Druyts; Mark Dybul; Steve Kanters; Jean Nachega; Josephine Birungi; Nathan Ford; Kristian Thorlund; Joel Negin; Richard Lester; Sanni Yaya; Edward J Mills Journal: AIDS Date: 2013-01-28 Impact factor: 4.177
Authors: Kathryn J Snow; Charalambos Sismanidis; Justin Denholm; Susan M Sawyer; Stephen M Graham Journal: Eur Respir J Date: 2018-02-21 Impact factor: 16.671
Authors: Muhammad Osman; Kevin Lee; Karen Du Preez; Rory Dunbar; Anneke C Hesseling; James A Seddon Journal: Clin Infect Dis Date: 2017-10-16 Impact factor: 9.079
Authors: Hmwe H Kyu; Christine Pinho; Joseph A Wagner; Jonathan C Brown; Amelia Bertozzi-Villa; Fiona J Charlson; Luc Edgar Coffeng; Lalit Dandona; Holly E Erskine; Alize J Ferrari; Christina Fitzmaurice; Thomas D Fleming; Mohammad H Forouzanfar; Nicholas Graetz; Caterina Guinovart; Juanita Haagsma; Hideki Higashi; Nicholas J Kassebaum; Heidi J Larson; Stephen S Lim; Ali H Mokdad; Maziar Moradi-Lakeh; Shaun V Odell; Gregory A Roth; Peter T Serina; Jeffrey D Stanaway; Awoke Misganaw; Harvey A Whiteford; Timothy M Wolock; Sarah Wulf Hanson; Foad Abd-Allah; Semaw Ferede Abera; Laith J Abu-Raddad; Fadia S AlBuhairan; Azmeraw T Amare; Carl Abelardo T Antonio; Al Artaman; Suzanne L Barker-Collo; Lope H Barrero; Corina Benjet; Isabela M Bensenor; Zulfiqar A Bhutta; Boris Bikbov; Alexandra Brazinova; Ismael Campos-Nonato; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Rajiv Chowdhury; Cyrus Cooper; John A Crump; Rakhi Dandona; Louisa Degenhardt; Robert P Dellavalle; Samath D Dharmaratne; Emerito Jose A Faraon; Valery L Feigin; Thomas Fürst; Johanna M Geleijnse; Bradford D Gessner; Katherine B Gibney; Atsushi Goto; David Gunnell; Graeme J Hankey; Roderick J Hay; John C Hornberger; H Dean Hosgood; Guoqing Hu; Kathryn H Jacobsen; Sudha P Jayaraman; Panniyammakal Jeemon; Jost B Jonas; André Karch; Daniel Kim; Sungroul Kim; Yoshihiro Kokubo; Barthelemy Kuate Defo; Burcu Kucuk Bicer; G Anil Kumar; Anders Larsson; Janet L Leasher; Ricky Leung; Yongmei Li; Steven E Lipshultz; Alan D Lopez; Paulo A Lotufo; Raimundas Lunevicius; Ronan A Lyons; Marek Majdan; Reza Malekzadeh; Taufiq Mashal; Amanda J Mason-Jones; Yohannes Adama Melaku; Ziad A Memish; Walter Mendoza; Ted R Miller; Charles N Mock; Joseph Murray; Sandra Nolte; In-Hwan Oh; Bolajoko Olubukunola Olusanya; Katrina F Ortblad; Eun-Kee Park; Angel J Paternina Caicedo; Scott B Patten; George C Patton; David M Pereira; Norberto Perico; Frédéric B Piel; Suzanne Polinder; Svetlana Popova; Farshad Pourmalek; D Alex Quistberg; Giuseppe Remuzzi; Alina Rodriguez; David Rojas-Rueda; Dietrich Rothenbacher; David H Rothstein; Juan Sanabria; Itamar S Santos; David C Schwebel; Sadaf G Sepanlou; Amira Shaheen; Rahman Shiri; Ivy Shiue; Vegard Skirbekk; Karen Sliwa; Chandrashekhar T Sreeramareddy; Dan J Stein; Timothy J Steiner; Lars Jacob Stovner; Bryan L Sykes; Karen M Tabb; Abdullah Sulieman Terkawi; Alan J Thomson; Andrew L Thorne-Lyman; Jeffrey Allen Towbin; Kingsley Nnanna Ukwaja; Tommi Vasankari; Narayanaswamy Venketasubramanian; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Elisabete Weiderpass; Robert G Weintraub; Andrea Werdecker; James D Wilkinson; Solomon Meseret Woldeyohannes; Charles D A Wolfe; Yuichiro Yano; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Chuanhua Yu; Maysaa El Sayed Zaki; Mohsen Naghavi; Christopher J L Murray; Theo Vos Journal: JAMA Pediatr Date: 2016-03 Impact factor: 16.193
Authors: Olurotimi A Adejumo; Kathleen M Malee; Patrick Ryscavage; Scott J Hunter; Babafemi O Taiwo Journal: J Int AIDS Soc Date: 2015-09-16 Impact factor: 5.396
Authors: Katherine C Horton; Peter MacPherson; Rein M G J Houben; Richard G White; Elizabeth L Corbett Journal: PLoS Med Date: 2016-09-06 Impact factor: 11.069
Authors: Alexander W Kay; Helena Rabie; Elizabeth Maleche-Obimbo; Moorine Penninah Sekadde; Mark F Cotton; Anna M Mandalakas Journal: Pathogens Date: 2021-12-29
Authors: Patricia Moscibrodzki; Leslie A Enane; Graeme Hoddinott; Meredith B Brooks; Virginia Byron; Jennifer Furin; James A Seddon; Lily Meyersohn; Silvia S Chiang Journal: Pathogens Date: 2021-12-08